Rep. Cohen will introduce bill to legalize medical marijuana use in PA
He will model the bill after one currently in consideration in New Jersey.
All Lancaster Co. residents eligible for new prescription drug discount program
The cards can be used by anyone — regardless of age, income or existing health care coverage — to buy prescription drugs for themselves, their pets and their farm animals; reports the Intelligencer Journal.
Business editor: New state-run prescription price finder is a start, not a solution to medication problems
Ron Bartizek uses a personal example to describe one fault with the prescription price-finding website.
New state website lets consumer compare the cost of their prescriptions
The new tool gives consumers a list of local pharmacies, and each pharmacy’s price for a medication.
Study: Most seniors did not make the best possible financial decision in choosing Medicare Part D drug plan
The study examined seniors’ drug claims for 2005 compared to their plan cost for 2006.
Sen. McCain among those to introduce bill to allow prescription drug reimportation
The proposal to allow drug imports is expected to receive strong backing from the Obama administration.
Study says treating some heart attacks with drugs alone is just as effective as using stents
In addition to being non-invasive, the drugs are less costly than stents.
Study examines how consumers get their info about medications
Consumers are more likely to receive information about medications from magazine advertisements that include a “drug facts box,” rather than the brief summaries currently used, writes Kaiser Network News.
Will drug companies soon be banned from advertising directly to consumers?
Obama’s administration looks to be more open to changing the rules on direct-to-consumer advertising by drug companies.
New FDA rule allowing drug companies to more often promote off-label drug uses draws approval, criticism
While supporters of the rule say that it will allow physicians to better explore the most up-to-date treatment options, opponents say it will lead to a decline in drug safety.